Attending #NeurIPS2024 ! Just arrived in Vancouver. Let me know if you’re around and want to grab a coffee and chat about drug discovery, structural biology, diffusion models, and other interesting work happening at Genesis.
Ken Leidal retweeted
Thrilled to announce Boltz-1, the first open-source and commercially available model to achieve AlphaFold3-level accuracy on biomolecular structure prediction! An exciting collaboration with @jeremyWohlwend, @pas_saro and an amazing team at MIT and Genesis Therapeutics. A thread!
Ken Leidal retweeted
It’s an exciting time to work at Genesis Therapeutics! I learned so much about ML for drug discovery from working on #GEMS with my mentors @KenLeidal and @alshedivat in my internship this summer!
Genesis Therapeutics lands a stellar $200M Series B! Their #GEMS platform is leading the way, blending AI with physical insights for next-gen treatments. Congrats to @enfeinberg & the team!
endpts.com/genesis-therapeut…
Ken Leidal retweeted
Kudos to the amazing team at @Path_AI for making this happen! Shima Nofallah, Maryam Pouryahya, Janani Iyer, @KenLeidal, John Abel, @alibehrooz (8/8)
Ken Leidal retweeted
If you are interested in this line of research, join us at our talk at the workshop on Computer Vision for Microscopy Image Analysis on June 19th at 2:52 PM CT. (7/8)
Ken Leidal retweeted
Beyond NASH, this paper provides a general method for incorporating multiple modalities of image information into a single inference without the need to align the images beforehand–critical for working on multi-stain problems in pathology. (6/8)
Ken Leidal retweeted
In NASH, we found that inferring scores from fused H&E and Trichrome graphs yielded upto 20% better concordance with a panel of pathologists. Importantly, we show our results on data from 6 clinical trials, demonstrating viability of our approach in real-world conditions. (5/8)
Ken Leidal retweeted
Our proposed GNN fusion model aggregates human interpretable CNN features via graph representations of non-registered whole slide images of differently-stained tissue specimens. This model extracts and integrates complementary multimodal information for disease staging. (4/8)
Ken Leidal retweeted
When pathologists assess slides, such as when grading and staging liver tissue in non-alcoholic steatohepatitis (NASH), they view tissue samples from the same patient with different stains to reveal complementary information about the diseased tissue. (3/8)
Ken Leidal retweeted
In computational pathology, it’s more common to infer on single slides rather than a set of slides that may uniquely characterize a disease. To overcome limitations of the one-model-per-modality structure, we present a single fusion model that leverages multiple slides. (2/8)
Ken Leidal retweeted
Excited to be presenting our recent work “Multi stain graph fusion for multimodal integration in pathology” at CVPR 2022. 🧵
Paper: openaccess.thecvf.com/conten…
#CVPR2022 #ComputationalPathology #ArtificialIntelligence (1/8)




